Cargando…
The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
Elevated iron in the SNpc may play a key role in Parkinson’s disease (PD) neurodegeneration since drug candidates with high iron affinity rescue PD animal models, and one candidate, deferirpone, has shown efficacy recently in a phase two clinical trial. However, strong iron chelators may perturb ess...
Autores principales: | Finkelstein, David I., Billings, Jessica L., Adlard, Paul A., Ayton, Scott, Sedjahtera, Amelia, Masters, Colin L., Wilkins, Simon, Shackleford, David M., Charman, Susan A., Bal, Wojciech, Zawisza, Izabela A, Kurowska, Ewa, Gundlach, Andrew L., Ma, Sheri, Bush, Ashley I., Hare, Dominic J., Doble, Philip A., Crawford, Simon, Gautier, Elisabeth CL., Parsons, Jack, Huggins, Penny, Barnham, Kevin J., Cherny, Robert A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5490188/ https://www.ncbi.nlm.nih.gov/pubmed/28659169 http://dx.doi.org/10.1186/s40478-017-0456-2 |
Ejemplares similares
-
Correction to: The novel compound PBT434 prevents iron mediated neurodegeneration and alpha-synuclein toxicity in multiple models of Parkinson’s disease
por: Finkelstein, David I., et al.
Publicado: (2021) -
The Compound ATH434 Prevents Alpha-Synuclein Toxicity in a Murine Model of Multiple System Atrophy
por: Finkelstein, David I., et al.
Publicado: (2022) -
ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism
por: Beauchamp, Leah C., et al.
Publicado: (2022) -
ATH434 Reverses Colorectal Dysfunction in the A53T Mouse Model of Parkinson’s Disease
por: Diwakarla, Shanti, et al.
Publicado: (2021) -
A novel approach to rapidly prevent age-related cognitive decline
por: Adlard, Paul A, et al.
Publicado: (2014)